Latest Insider Transactions at Pdl Biopharma, Inc. (PDLI)
This section provides a real-time view of insider transactions for Pdl Biopharma, Inc. (PDLI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PDL BIOPHARMA, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PDL BIOPHARMA, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 01
2021
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
187,061
+0.77%
|
$374,122
$2.05 P/Share
|
Dec 30
2020
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,325,213
+21.01%
|
$12,650,426
$2.5 P/Share
|
Dec 30
2020
|
David W Gryska Director |
SELL
Open market or private sale
|
Direct |
20,000
-93.51%
|
$40,000
$2.74 P/Share
|
Dec 29
2020
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
268,600
+1.52%
|
$537,200
$2.69 P/Share
|
Dec 28
2020
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
235,000
+1.35%
|
$470,000
$2.7 P/Share
|
Dec 24
2020
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
128,000
+0.75%
|
$256,000
$2.65 P/Share
|
Dec 23
2020
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
485,000
+2.8%
|
$970,000
$2.6 P/Share
|
Dec 22
2020
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
850,000
+4.94%
|
$1,700,000
$2.59 P/Share
|
Dec 22
2020
|
John Peter Mclaughlin Director |
SELL
Open market or private sale
|
Direct |
277,934
-58.15%
|
$555,868
$2.61 P/Share
|
Dec 21
2020
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
230,000
+1.46%
|
$460,000
$2.63 P/Share
|
Dec 21
2020
|
John Peter Mclaughlin Director |
SELL
Open market or private sale
|
Direct |
50,000
-9.47%
|
$100,000
$2.62 P/Share
|
Dec 17
2020
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
398,000
+2.54%
|
$796,000
$2.61 P/Share
|
Dec 16
2020
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,350,000
+8.33%
|
$2,700,000
$2.58 P/Share
|
Dec 16
2020
|
David W Gryska Director |
SELL
Open market or private sale
|
Direct |
75,000
-77.81%
|
$150,000
$2.68 P/Share
|
Dec 16
2020
|
Dominique Monnet President and CEO |
SELL
Open market or private sale
|
Direct |
500,000
-40.49%
|
$1,000,000
$2.6 P/Share
|
Dec 16
2020
|
Christopher Lewis Stone VP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
200,000
-33.03%
|
$400,000
$2.56 P/Share
|
Dec 15
2020
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000,000
+6.89%
|
$2,000,000
$2.59 P/Share
|
Dec 14
2020
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
640,000
+4.87%
|
$1,280,000
$2.62 P/Share
|
Dec 11
2020
|
Silver Point Capital L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
450,000
+3.65%
|
$900,000
$2.45 P/Share
|
Dec 05
2020
|
David W Gryska Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66,050
+40.66%
|
$66,050
$1.64 P/Share
|
Dec 03
2020
|
David W Gryska Director |
SELL
Open market or private sale
|
Direct |
75,000
-71.2%
|
$150,000
$2.52 P/Share
|
Dec 02
2020
|
Christopher Lewis Stone VP, Gen. Counsel & Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,544
-1.87%
|
-
|
Nov 23
2020
|
David W Gryska Director |
SELL
Open market or private sale
|
Direct |
50,000
-32.19%
|
$100,000
$2.43 P/Share
|
Nov 23
2020
|
Elizabeth G. O'Farrell Director |
SELL
Open market or private sale
|
Direct |
25,826
-100.0%
|
$51,652
$2.44 P/Share
|
Nov 20
2020
|
Alan Lee Bazaar Director |
SELL
Open market or private sale
|
Direct |
33,435
-76.21%
|
$66,870
$2.42 P/Share
|
Nov 18
2020
|
Alan Lee Bazaar Director |
SELL
Payment of exercise price or tax liability
|
Direct |
26,642
-37.78%
|
$53,284
$2.38 P/Share
|
Nov 18
2020
|
Alan Lee Bazaar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
37,080
+34.46%
|
$37,080
$1.71 P/Share
|
Nov 18
2020
|
David W Gryska Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+27.86%
|
$60,000
$1.64 P/Share
|
Nov 18
2020
|
Elizabeth G. O'Farrell Director |
SELL
Open market or private sale
|
Direct |
63,291
-71.02%
|
$126,582
$2.38 P/Share
|
Nov 18
2020
|
David W Gryska Director |
SELL
Open market or private sale
|
Direct |
50,000
-34.4%
|
$100,000
$2.39 P/Share
|
Nov 17
2020
|
David W Gryska Director |
SELL
Open market or private sale
|
Direct |
100,000
-40.76%
|
$200,000
$2.4 P/Share
|